Tobacco pack display at hospitality venues after the introduction of standardised tobacco packaging in New Zealand: a field observation study.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
06 09 2019
Historique:
entrez: 9 9 2019
pubmed: 9 9 2019
medline: 26 9 2020
Statut: epublish

Résumé

In March 2018, New Zealand (NZ) introduced standardised tobacco packaging that also featured new pictorial warnings, with implementation completed by early June 2018. We evaluated how the new packaging affected tobacco pack displays in outdoor areas of hospitality venues. Before-and-after descriptive field observation study. Central city area of the capital city of NZ (Wellington). Observations of people smoking and tobacco packs were made at 56 hospitality venues with outdoor tables (2422 separate venue observations), after the introduction of standardised tobacco packaging. Comparisons were made with a prior study in the same setting, from a time when tobacco packaging still featured brand imagery. A total of 8191 patrons, 1113 active smokers and 889 packs and pouches (522 of known orientation) were observed over 2422 venue observations. There were 0.80 visible packs per active smoker in 2018, compared with 1.26 in 2014 (risk ratio (RR)=0.64, 95% CI 0.60 to 0.67, p<0.0001). The new packs in 2018 were also less likely to be displayed face-up, compared with packs in 2014, which had brand imagery on the front face (RR=0.77, 95% CI 0.72 to 0.83, p<0.0001). Pack and pouch display (RR=3.09 in 2014 and 3.10 in 2018) and active smoking (RR=3.16 in 2014 compared with 3.32 in 2018) were higher at venues without children present, compared with venues with children present (this finding was consistent over time). The reduction in the number of visible packs per active smoker, along with the reduction in face-up positioning of packs, suggests that smokers found the new standardised packs less attractive. Countries introducing standardised packaging should consider evaluating social display of tobacco packaging.

Identifiants

pubmed: 31494599
pii: bmjopen-2018-027868
doi: 10.1136/bmjopen-2018-027868
pmc: PMC6731942
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e027868

Informations de copyright

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Tob Control. 2011 Sep;20(5):327-37
pubmed: 21606180
Qual Health Res. 2012 May;22(5):630-9
pubmed: 22203384
J Adolesc Health. 2013 Feb;52(2):151-7
pubmed: 23332478
Tob Control. 2014 Jul;23(4):339-44
pubmed: 23427292
Addiction. 2013 Sep;108(9):1658-68
pubmed: 23600674
Environ Health Perspect. 2013 Jul;121(7):766-73
pubmed: 23651671
Prev Med. 2014 Feb;59:73-8
pubmed: 24291748
Addiction. 2014 Apr;109(4):653-62
pubmed: 24428427
Prev Med. 2014 Jul;64:37-40
pubmed: 24704133
BMC Public Health. 2014 Apr 06;14:300
pubmed: 24708883
N Z Med J. 2014 Oct 17;127(1404):27-36
pubmed: 25331309
Tob Control. 2016 Jan;25(1):83-8
pubmed: 25352563
Tob Control. 2016 Mar;25(2):160-5
pubmed: 25808667
Tob Control. 2016 Jul;25(4):458-63
pubmed: 26138823
N Z Med J. 2016 Jan 08;129(1428):93-7
pubmed: 26914199
Tob Control. 2015 Apr;24(Suppl 2):ii17-ii25
pubmed: 28407606
Tob Control. 2015 Apr;24(Suppl 2):ii94-ii97
pubmed: 28407618
Cochrane Database Syst Rev. 2017 Apr 27;4:CD011244
pubmed: 28447363
Eur J Public Health. 2018 Aug 1;28(4):702-707
pubmed: 29596579

Auteurs

Johanna Nee-Nee (J)

Department of Public Health, University of Otago, Wellington, New Zealand.

Kirsty Sutherland (K)

Department of Public Health, University of Otago, Wellington, New Zealand.

Rebecca Holland (R)

Department of Public Health, University of Otago, Wellington, New Zealand.

Miriam Wilson (M)

Department of Public Health, University of Otago, Wellington, New Zealand.

Samuel Ackland (S)

Department of Public Health, University of Otago, Wellington, New Zealand.

Claudia Bocock (C)

Department of Public Health, University of Otago, Wellington, New Zealand.

Abbie Cartmell (A)

Department of Public Health, University of Otago, Wellington, New Zealand.

Jack Earp (J)

Department of Public Health, University of Otago, Wellington, New Zealand.

Christina Grove (C)

Department of Public Health, University of Otago, Wellington, New Zealand.

Charlotte Hewson (C)

Department of Public Health, University of Otago, Wellington, New Zealand.

Will Jefferies (W)

Department of Public Health, University of Otago, Wellington, New Zealand.

Lucy Keefe (L)

Department of Public Health, University of Otago, Wellington, New Zealand.

Jamie Lockyer (J)

Department of Public Health, University of Otago, Wellington, New Zealand.

Saloni Patel (S)

Department of Public Health, University of Otago, Wellington, New Zealand.

Miguel Quintans (M)

Department of Public Health, University of Otago, Wellington, New Zealand.

Michael Robbie (M)

Department of Public Health, University of Otago, Wellington, New Zealand.

Lauren Teape (L)

Department of Public Health, University of Otago, Wellington, New Zealand.

Jess Yang (J)

Department of Public Health, University of Otago, Wellington, New Zealand.

Nick Wilson (N)

Department of Public Health, University of Otago, Wellington, New Zealand.

Janet Hoek (J)

Department of Public Health, University of Otago, Wellington, New Zealand.

George Thomson (G)

Department of Public Health, University of Otago, Wellington, New Zealand george.thomson@otago.ac.nz.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH